Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 37 | 12/04/21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13/04/21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/17 |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
John P. Clark
AUD | Comptroller/Controller/Auditor | 52 | 20/11/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02/02/16 |
Daniel Kazado
BRD | Director/Board Member | 59 | 10/10/13 |
Jeff Paley
BRD | Director/Board Member | 55 | 23/02/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 3 713 | 0 | 0 | 100,00 % |
Acción B | 1 | 172 878 093 | 172 878 093 ( 100,00 %) | 0 |
Información de la empresa
Immune Pharmaceuticals, Inc.
1 Bridge Plaza North Suite 270
07024, Englewood Cliffs
+201-464-2677
http://www.immunepharma.comVaria. 1 de ene. | Capi. | |
---|---|---|
+61,53 % | 856 mil M | |
+38,95 % | 631 mil M | |
-3,66 % | 359 mil M | |
+15,06 % | 325 mil M | |
+9,18 % | 297 mil M | |
+5,89 % | 234 mil M | |
+16,53 % | 226 mil M | |
+15,67 % | 177 mil M | |
+2,47 % | 165 mil M |
- Bolsa de valores
- Acciones
- Acción FZRQ
- Acción
- Empresa Immune Pharmaceuticals Inc